BACKGROUND: Convexity meningiomas are common tumors requiring treatment in patients with neurofibromatosis type 2 (NF2). Although different therapeutic options are described for sporadic convexity meningioma, much less is known about these lesions in patients with NF2 despite their distinct biology and need for multiple treatments. We analyzed the value of Gamma Knife radiosurgery (GKRS) as definitive treatment for convexity meningiomas in patients with NF2. METHODS: This international multicenter retrospective study was approved by the International Radiosurgery Research Foundation. Patients with NF2 with at least 1 convexity meningioma and 6-month follow-up after primary GKRS were included. RESULTS: Inclusion criteria were met by 18 patients with NF2. A total of 120 convexity meningiomas (median treatment volume, 0.66 cm3 [range, 0.10-21.20 cm3]) were analyzed. Median follow-up after initial GKRS was 15.6 years (range, 0.6-25.5 years). Median age at GKRS was 32.5 years (range, 16-53 years). Median number of meningiomas per patient was 13 (range, 1-27), and median number of convexity lesions receiving GKRS per patient was 3.5 (range, 1-27). One case of tumor progression was reported 24 years after GKRS, leading to actuarial progression-free survival rates of 100% at 2, 5, and 10 years. No malignant transformation or death due to meningioma or radiosurgery was recorded. CONCLUSIONS: GKRS is safe and effective as definitive treatment of small to medium-sized convexity meningiomas in patients with NF2. Despite concerns about the particular mutational burden of these tumors, no malignant transformation manifested after treatment. GKRS represents a minimally invasive option that offers long-term tumor control to this specific group of patients.

Department of Neurological Surgery Centre de recherche du CHUS Université de Sherbrooke Sherbrooke Quebec Canada

Department of Neurological Surgery Na Homolce Hospital Prague Czech Republic

Department of Neurological Surgery University of Virginia Charlottesville Virginia USA

Department of Neurological Surgery West Virginia University Morgantown Virginia USA

Department of Radiation Oncology Mayo Clinic Jacksonville Florida USA; Department of Neurological Surgery Mayo Clinic Jacksonville Florida USA

Dominican Gamma Knife Center and CEDIMAT Hospital Santo Domingo Dominican Republic

House Ear Institute Los Angeles California USA

Post Graduate Institute of Medical Education and Research Chandigarh India

Zobrazit více v PubMed

Celtikci E, Kaymaz AM, Akgul G, Karaaslan B, Emmez OH, Borcek A. Retrospective analysis of 449 intracranial meningioma patients operated between 2007 and 2013 at a single institute. Turk Neurosurg. 2018;28:1–6. PubMed

Black PM, Morokoff AP, Zauberman J. Surgery for extra-axial tumors of the cerebral convexity and midline. Neurosurgery. 2008;62(6 Suppl 3):1115–1121 [discussion: 1121–1123]. PubMed

Sanai N, Sughrue ME, Shangari G, Chung K, Berger MS, McDermott MW. Risk profile associated with convexity meningioma resection in the modern neurosurgical era. J Neurosurg. 2010;112: 913–919. PubMed

Gupta A, Xu Z, Cohen-Inbar O, et al. Treatment of asymptomatic meningioma with Gamma Knife radiosurgery: long-term follow-up with volumetric assessment and clinical outcome. Clin Neurosurg. 2019;85:E889–E899. PubMed

Sughrue ME, Rutkowski MJ, Aranda D, Barani IJ, McDermott MW, Parsa AT. Treatment decision making based on the published natural history and growth rate of small meningiomas. J Neurosurg. 2010;113:1036–1042. PubMed

Sarris C, Sanai N. Convexity meningioma resection in the modern neurosurgical era. Handb Clin Neurol. 2020;170:87–92. PubMed

Kondziolka D, Madhok R, Dade Lunsford L, et al. Stereotactic radiosurgery for convexity meningiomas. J Neurosurg. 2009;111:458–463. PubMed

Smith MJ, Higgs JE, Bowers NL, et al. Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onset. J Med Genet. 2011;48:261–265. PubMed

Goutagny S, Kalamarides M. Meningiomas and neurofibromatosis. J Neurooncol. 2010;99:341–347. PubMed

Dirks MS, Butman JA, Kim HJ, et al. Long-term natural history of neurofibromatosis type 2-associated intracranial tumors. J Neurosurg. 2012; 117:109–117. PubMed PMC

Evers S, Verbaan D, Sanchez E, Peerdeman S. 3D volumetric measurement of neurofibromatosis type 2-associated meningiomas: association between tumor location and growth rate. World Neurosurg. 2015;84:1062–1069. PubMed

Goutagny S, Bah AB, Henin D, et al. Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features. Neuro Oncol. 2012;14: 1090–1096. PubMed PMC

Li P, Wu T, Wang Y, et al. Clinical features of newly developed NF2 intracranial meningiomas through comparative analysis of pediatric and adult patients. Clin Neurol Neurosurg. 2020;194: 105799. PubMed

Liu A, Kuhn EN, Lucas JT, Laxton AW, Tatter SB, Chan MD. Gamma Knife radiosurgery for meningiomas in patients with neurofibromatosis Type 2. J Neurosurg. 2015;122:536–542. PubMed PMC

Baser ME, Friedman JM, Aeschliman D, et al. Predictors of the risk of mortality in neurofibromatosis 2. Am J Hum Genet. 2002;71:715–723. PubMed PMC

Goutagny S, Yang HW, Zucman-Rossi J, et al. Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status. Clin Cancer Res. 2010;16:4155–4164. PubMed

Bi WL, Abedalthagafi M, Horowitz P, et al. Genomic landscape of intracranial meningiomas. J Neurosurg. 2016;125:525–535. PubMed

Lee S, Karas PJ, Hadley CC, et al. The role of Merlin/NF2 loss in meningioma biology. Cancers (Basel). 2019;11:1633. PubMed PMC

Walker AJ, Ruzevick J, Malayeri AA, et al. Post-radiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression? Future Oncol. 2014;10: 1277–1297. PubMed PMC

Patibandla MR, Lee CC, Tata A, Addagada GC, Sheehan JP. Stereotactic radiosurgery for WHO grade I posterior fossa meningiomas: long-term outcomes with volumetric evaluation. J Neurosurg. 2018;129:1249–1259. PubMed

Mehta GU, Zenonos G, Patibandla MR, et al. Outcomes of stereotactic radiosurgery for foramen magnum meningiomas: an international multicenter study. J Neurosurg. 2018;129:383–389. PubMed

Aboukais R, Zairi F, Baroncini M, et al. Intracranial meningiomas and neurofibromatosis type 2. Acta Neurochir (Wien). 2013;155:997–1001 [discussion: 1001]. PubMed

Meningiomas. Their classification, regional behaviour, life history, and surgical end results. Bull Med Libr Assoc. 1938;27:185.

Girvigian MR, Chen JC, Rahimian J, Miller MJ, Tome M. Comparison of early complications for patients with convexity and parasagittal meningiomas treated with either stereotactic radiosurgery or fractionated stereotactic radiotherapy. Neurosurgery. 2008;62(5 Suppl):A19–A27 [discussion: A27-A28]. PubMed

Hasegawa T, Kida Y, Yoshimoto M, Iizuka H, Ishii D, Yoshida K. Gamma Knife surgery for convexity, parasagittal, and falcine meningiomas. J Neurosurg. 2011;114:1392–1398. PubMed

Morokoff AP, Zauberman J, Black PM. Surgery for convexity meningiomas. Neurosurgery. 2008;63: 427–433 [discussion: 433–434]. PubMed

Alvernia JE, Dang ND, Sindou MP. Convexity meningiomas: study of recurrence factors with special emphasis on the cleavage plane in a series of 100 consecutive patients. J Neurosurg. 2011;115: 491–498. PubMed

Nguyen T, Chung LK, Sheppard JP, et al. Surgery versus stereotactic radiosurgery for the treatment of multiple meningiomas in neurofibromatosis type 2: illustrative case and systematic review. Neurosurg Rev. 2019;42:85–96. PubMed

Pollock BE, Stafford SL, Utter A, Giannini C, Schreiner SA. Stereotactic radiosurgery provides equivalent tumor control to Simpson Grade 1 resection for patients with small- to medium-size meningiomas. Int J Radiat Oncol Biol Phys. 2003;55: 1000–1005. PubMed

Salvetti DJ, Nagaraja TG, Levy C, Xu Z, Sheehan J. Gamma Knife surgery for the treatment of patients with asymptomatic meningiomas. J Neurosurg. 2013;119:487–493. PubMed

Sheehan JP, Starke RM, Kano H, et al. Gamma Knife radiosurgery for posterior fossa meningiomas: a multicenter study. J Neurosurg. 2015;122: 1479–1489. PubMed

Sheehan JP, Williams BJ, Yen CP. Stereotactic radiosurgery for WHO grade I meningiomas. J Neurooncol. 2010;99:407–416. PubMed

Starke RM, Nguyen JH, Rainey J, et al. Gamma Knife surgery of meningiomas located in the posterior fossa: factors predictive of outcome and remission. J Neurosurg. 2011;114:1399–1409. PubMed

Starke RM, Nguyen JH, Reames DL, Rainey J, Sheehan JP. Gamma Knife radiosurgery of meningiomas involving the foramen magnum. J Craniovertebr Junction Spine. 2010;1:23–28. PubMed PMC

Starke RM, Przybylowski CJ, Sugoto M, et al. Gamma Knife radiosurgery of large skull base meningiomas. J Neurosurg. 2015;122:363–372. PubMed

Starke RM, Williams BJ, Hiles C, Nguyen JH, Elsharkawy MY, Sheehan JP. Gamma knife surgery for skull base meningiomas. J Neurosurg. 2012;116: 588–597. PubMed

Williams BJ, Yen CP, Starke RM, et al. Gamma Knife surgery for parasellar meningiomas: long-term results including complications, predictive factors, and progression-free survival. J Neurosurg. 2011;114:1571–1577. PubMed

Kondziolka D, Levy EI, Niranjan A, Flickinger JC, Lunsford LD. Long-term outcomes after meningioma radiosurgery: physician and patient perspectives. J Neurosurg. 1999;91:44–50. PubMed

Kondziolka D, Lunsford LD, Coffey RJ, Flickinger JC. Stereotactic radiosurgery of meningiomas. J Neurosurg. 1991;74:552–559. PubMed

Kondziolka D, Lunsford LD, Coffey RJ, Flickinger JC. Gamma Knife radiosurgery of meningiomas. Stereotact Funct Neurosurg. 1991;57:11–21. PubMed

Santacroce A, Walier M, Regis J, et al. Long-term tumor control of benign intracranial meningiomas after radiosurgery in a series of 4565 patients. Neurosurgery. 2012;70:32–39. PubMed

Baser ME, Evans DG, Jackler RK, Sujansky E, Rubenstein A. Neurofibromatosis 2, radiosurgery and malignant nervous system tumours. Br J Cancer. 2000;82:998. PubMed PMC

Evans DG, Birch JM, Ramsden RT, Sharif S, Baser ME. Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes. J Med Genet. 2006;43:289–294. PubMed PMC

Birckhead B, Sio TT, Pollock BE, Link MJ, Laack NN. Gamma Knife radiosurgery for neurofibromatosis type 2-associated meningiomas: a 22-year patient series. J Neurooncol. 2016; 130:553–560. PubMed

Gao F, Li M, Wang Z, Shi L, Lou L, Zhou J. Efficacy and safety of gamma knife radiosurgery for meningiomas in patients with neurofibromatosis type 2: a long-term follow-up single-center study. World Neurosurg. 2019;125:e929–e936. PubMed

Flickinger JC, Kondziolka D, Maitz AH, Lunsford LD. Gamma Knife radiosurgery of imaging-diagnosed intracranial meningioma. Int J Radiat Oncol Biol Phys. 2003;56:801–806. PubMed